BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...including HOPU Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...including HOPU Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life...
BioCentury | Aug 10, 2018
Financial News

SQZ raises $72M series C

...Aug. 8 in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life...
BioCentury | Aug 8, 2018
Financial News

SQZ raises $72M series C

...$72 million in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life...
BioCentury | Jul 21, 2008
Finance

Ebb & Flow

In the largest untranched biotech financing this year, genome sequencing company Pacific Biosciences (formerly Nanofluidics) raised $100 million last week in a series E round. The company now has raised $178 million since it was...
Items per page:
1 - 5 of 5
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...including HOPU Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...including HOPU Investments, Gilead Sciences Inc. (NASDAQ:GILD), Invus, the Bill & Melinda Gates Foundation and Orient Life...
BioCentury | Aug 10, 2018
Financial News

SQZ raises $72M series C

...Aug. 8 in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life...
BioCentury | Aug 8, 2018
Financial News

SQZ raises $72M series C

...$72 million in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life...
BioCentury | Jul 21, 2008
Finance

Ebb & Flow

In the largest untranched biotech financing this year, genome sequencing company Pacific Biosciences (formerly Nanofluidics) raised $100 million last week in a series E round. The company now has raised $178 million since it was...
Items per page:
1 - 5 of 5